School of Medicine

The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.

Sarah Ackerman, an assistant professor of pathology and immunology at the School of Medicine, has received a 2023 Klingenstein-Simons Fellowship Award in Neuroscience.

Led by the School of Medicine and other institutions around the world, the Clinical Proteomic Tumor Analysis Consortium has completed a deep analysis of the proteins driving cancer across multiple tumor types. The findings could help lead to new therapies.

Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, has earned a prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing continued excellence in cancer care, research, training, prevention and community outreach.

Washington University School of Medicine’s Alpha Omega Alpha chapter has chosen 24 faculty members, alumni and house officers-in-training to be new members of the medical honor society.

Linda Repa-Eschen, former business director for the Division of Endocrinology, Metabolism & Lipid Research within the Department of Medicine at the School of Medicine, died June 5 at her home after waiting for a lung transplant. She was 72.

People with Down syndrome are at very high risk of developing Alzheimer’s disease. A project led by Jason Hassenstab, at the School of Medicine, aims to develop tools to measure cognitive function in people with Down syndrome-associated Alzheimer’s disease.

Members of minoritized racial or ethnic groups and people who live in less affluent neighborhoods are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from the School of Medicine indicates.

Philip R.O. Payne, at the School of Medicine, has joined the steering committee of a National Academy of Medicine working group to draft a code of conduct for artificial intelligence in health, medical care and health research.

Scientists at Washington University have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.